Quantitative CT Phenotypes and Prognosis in Combined Pulmonary Fibrosis and Emphysema.
Authors
Affiliations (9)
Affiliations (9)
- Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- National Center for Respiratory Medicine; State Key Laboratory of Respiratory Health and Multimorbidity; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
- Department of Radiology, State Key Laboratory of Respiratory Health and Multimorbidity, China-Japan Friendship Hospital, 2 Yinghua Dong St, Chaoyang District, Beijing 100029, China.
- Department of Radiology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
- Department of Radiology, The Second Hospital of Jilin University, Changchun, Jilin, China.
- Capital Medical University, Beijing, China.
- Department of Pulmonary and Critical Care Medicine, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
- Department of Radiology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
- Department of Pulmonary and Critical Care Medicine, Beijing Anzhen Hospital, Beijing, China.
Abstract
Background Combined pulmonary fibrosis and emphysema (CPFE) has heterogeneous outcomes, and visual assessment or separate measurement of emphysema and fibrosis does not directly identify which structural component predominates in an individual patient. Purpose To determine whether quantitative CT enables objective stratification of CPFE into fibrosis-dominant and emphysema-dominant phenotypes and to evaluate their distinct clinical trajectories and prognostic implications. Materials and Methods This secondary analysis of a prospective multicenter observational study included patients with CPFE enrolled between January 2017 and December 2024. A fixed commercial artificial intelligence workstation automatically segmented the lungs and quantified emphysema and fibrosis on high-resolution CT scans. Participants were classified as having the fibrosis-dominant phenotype when the fibrosis percentage was equal to or greater than the emphysema percentage, and as having the emphysema-dominant phenotype otherwise. Group comparisons used the <i>t</i> test, Wilcoxon rank-sum test, χ<sup>2</sup> test, or Fisher exact test. Cox models were used to assess all-cause mortality; C index and calibration were used to assess model performance. Results The study population included 1583 participants (median age, 65 years [IQR, 58-71 years]; 1186 men); 823 (52%) had the fibrosis-dominant phenotype, and 760 (48%) had the emphysema-dominant phenotype. The fibrosis-dominant group had a higher fibrosis percentage than the emphysema-dominant group (median, 18% vs 10%; <i>P</i> < .001), whereas the emphysema-dominant group had a higher emphysema percentage (median, 7% vs 6%; <i>P</i> < .001). During a median follow-up of 2.59 years, 513 deaths occurred. The fibrosis-dominant phenotype was associated with higher mortality after adjustment (hazard ratio, 1.36 [95% CI: 1.13, 1.62]; <i>P</i> < .001). Conclusion Quantitative CT helped identify emphysema- and fibrosis-dominant CPFE phenotypes with different prognoses. The fibrosis-dominant phenotype was associated with higher all-cause mortality. Clinical trial registration no. NCT04370158 © RSNA, 2026 <i>Supplemental material is available for this article.</i> See also the editorial by Grenier in this issue.